Ray Dalio acquired 97.9 Thousand Dexcom shares worth $8.29 Million. That's 0.04% of their equity portfolio (274th largest holding). The first Dexcom trade was made in Q3 2020. Since then Ray Dalio bought shares eight more times and sold shares on nine occasions. The investor's estimated purchase price is $10.3 Million, resulting in a loss of 19%.